HMG CoA reductase inhibitor suppresses the expression of tissue factor and plasminogen activator inhibitor-1 induced by angiotensin II in cultured rat aortic endothelial cells

By Kunieda Y.   Nakagawa K.   Nishimura H.   Kato H.   Ukimura N.   Yano S.   Kawano H.   Kimura S.   Nakagawa M.   Tsuji H.  

Thrombosis Research, Vol. 110, Iss. 4, 2003-06 ,pp. : 227-234

Elsevier

Access to resources Recommend Favorite

HMG-CoA reductase inhibitor pharmacogenomics: overview and implications for practice

By Zineh Issam  

Future Cardiology, Vol. 1, Iss. 2, 2005-03 ,pp. : 191-206

Future Medicine

Access to resources Recommend Favorite

Effect of a selective thromboxane A₂ synthetase inhibitor on the systemic changes induced by circulating pancreatic phospholipase A₂

By Motoyoshi Makoto   Sugiyama Masanori   Atomi Yutaka   Kimura Wataru   Nagawa Hirokazu  

Journal of Gastroenterology, Vol. 41, Iss. 11, 2006-11 ,pp. : 1094-1098

Springer Publishing Company

Access to resources Recommend Favorite

Single administration of cerivastatin, an HMG-CoA reductase inhibitor, improves the coronary flow velocity reserve: a transthoracic Doppler echocardiography study

By Takagi Atsushi   Tsurumi Yukio   Ishizuka Naoko   Omori Hisako   Arai Kotaro   Hagiwara Nobuhisa   Kasanuki Hiroshi  

Heart and Vessels, Vol. 21, Iss. 5, 2006-09 ,pp. : 298-301

Springer Publishing Company

Access to resources Recommend Favorite

Effect of HMG-CoA Reductase Inhibition on Vascular Smooth Muscle Cells Extracellular Matrix Production: Role of RhoA

By  

Current Vascular Pharmacology, Vol. 14, Iss. 4, 2016-07 ,pp. : 345-352

Bentham Science Publishers

Access to resources Recommend Favorite